Gambia vs Greece: Access to anti-retroviral drugs, female
Gambia
55.0%
in 2024
Greece
57.0%
in 2024
Gambia rank
111th
Greece rank
108th
Access to anti-retroviral drugs, female over time
- Gambia
- Greece
How they compare
Greece currently reports 57.0% against 55.0% in Gambia, a difference of 2.0%.
Across all 25 years both countries report, Greece has been ahead every year.
Gambia ranks 111th and Greece ranks 108th of 141 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 44.3% | 42.7% | Greece |
| 2010s | 26.0% | 49.7% | 23.7% | Greece |
| 2020s | 48.0% | 55.6% | 7.6% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Gambia or Greece?
- Greece, at 57.0% against 55.0% in Gambia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Gambia and Greece?
- 2.0%, with Greece ahead.
- How many years of comparable data are there for Gambia and Greece?
- 25 years are reported by both, from 2000 to 2024.
- How do Gambia and Greece rank globally for access to anti-retroviral drugs, female?
- Gambia ranks 111th and Greece ranks 108th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.